Experimental validation demonstrated that knockdown of EZH2 resulted in downregulation of CLOCK and CRY1, suggesting that EZH2 may influence HCC progression by modulating these core circadian rhythm genes. This evidence concerns the gene EZH2 and hepatocellular carcinoma.